The NRG3/ERBB4 signaling cascade as a novel therapeutic target for canine glioma.
Sign Up to like & getrecommendations! Published in 2021 at "Experimental cell research"
DOI: 10.1016/j.yexcr.2021.112504
Abstract: Canine glioma is a common brain tumor with poor prognosis despite surgery and/or radiation therapy. Therefore, newer and more effective treatment modalities are needed. Neuregulin 3 (NRG3) has known to be a ligand of ERBB4.… read more here.
Keywords: glioma; canine glioma; target; nrg3 erbb4 ... See more keywords